Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV

Journal of Infectious Diseases

Volumn 200, Issue 4, 2009, Pages 619-623

  Allison, Robert D ^a   Katsounas, Antonios ^b   Koziol, Deloris E ^a   Kleiner, David E ^c   Alter, Harvey J ^a   Lempicki, Richard A ^e   Wood, Brad ^d   Yang, Jun ^a,e   Fullmer, Brandie ^e   Cortez, Karoll J ^a   Polis, Michael A ^b   Kottilil, Shyam ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 15; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; ANTIVIRUS AGENT;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; EVENING DOSAGE; FEMALE; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LIVER CELL; LIVER FIBROSIS; MALE; MIXED INFECTION; MORNING DOSAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STELLATE CELL; CYTOKINE INDUCED KILLER CELL; GENE EXPRESSION REGULATION; IMMUNOLOGY; ITO CELL; LYMPHOCYTE; METABOLISM; PHYSIOLOGY;

ANTIVIRAL AGENTS; CYTOKINE-INDUCED KILLER CELLS; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERLEUKIN-15; LYMPHOCYTES;

EID: 69149085590     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/600107     Document Type: Article

References (14)

1. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med 2003; 138:197-207.
2. 2. Thomas DL, Shih JW, Alter HJ, et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 1996; 174:690-695 (Pubitemid 26325882)
3. 3. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997;26:1-5. (Pubitemid 27072597)
4. 4. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 1999;30:1054-1058 (Pubitemid 29458296)
5. Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepa toi 2004; 1:98-105.
6. 6. Guido M, Rugge M, Leandro G, et al. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts. Hepatology 1997;26:310-314 (Pubitemid 27328306)
7. 7. Skalli O, Ropraz P, Trzeciak A, et al. A monoclonal antibody against a-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986; 103:2787-2796 (Pubitemid 17008024)
8. 8. Gugliotta P, Sapino A, Macri L, et al. Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody. J Histochem Cytochem 1988;36:659-663 (Pubitemid 18147088)
9. Schmitt-Graeff A, Krueger S, Bochard F, et al. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 1991; 138:1233-1242
10. Lempicki RA, Polis MA, Yang J, et al. Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: Class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. J Infect Dis 2006; 193:1172-1177
11. + T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003; 187:1534-1543
12. + T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus. J Infect Dis 2008; 197:1402-1407
13. 13. Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 2006;6:595-601. (Pubitemid 44134092)
14. 14. Brau N, Salvatore M, Rios-Bedoya CF, et al. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol 2006; 44:47-55. (Pubitemid 41772515)